Pharm-Olam International, LLC and each affiliate and subsidiary thereof (collectively referred to as Pharm-Olam) conducts every business transaction (including without limitation, operations, negotiations, and marketing) with integrity and complies with the laws and regulations of the United States, as well as the laws and regulations of each foreign country in which Pharm-Olam operates or is looking to operate. All Pharm-Olam personnel are expected to conduct Pharm-Olam business legally and ethically and with respect to maintaining privacy in communication.
Accordingly, Pharm-Olam intends that all transfers of personal information comply with all applicable international laws and regulations. Specifically, for example, for transfers of personal information from Switzerland and the EU to the US, Pharm-Olam follows and complies with the EU-US Privacy Shield and the Swiss-U.S. Privacy Shield Principles published by the U.S. Department of Commerce regarding the collection, use, and retention of such information (the “Privacy Principles”). Pharm-Olam certifies that it adheres to the Privacy Principles of notice, choice, onward transfer, security, data integrity, access, and enforcement. To learn more about the Privacy Shield please visit https://www.privacyshield.gov/list (link is external)(link is external). If there is any conflict between the policies in these privacy policies and the Privacy Principles, the Privacy Principles shall govern.
The Privacy Principles, the EU countries’ Data Protection Principles, and the data protection principles of any other relevant country or jurisdiction are collectively referred to as the “Principles” in this policy.
Further to these protections, Pharm-Olam also confirms its adherence to the Privacy and Data Protection laws of other countries such as those of Russia Federal Law of 27 July 2006 N 152-FZ ON PERSONAL DATA.
Pharm-Olam values the confidence of its customers, and vendors, and respects individual privacy, including personal information of employees, consumers, healthcare professionals, medical research subjects, clinical investigators, customers, business partners, consultants, contractors, subcontractors, and investors. Not only does Pharm-Olam strive to collect, use and disclose personal information in a manner consistent with the laws of the countries in which it does business, but it also has a tradition of upholding the highest ethical standards in its business practices.
To ensure implementation and enforcement of this policy, Pharm-Olam set up a task force which has been active since 2010, the members of which represent a cross-section of different departments and geographical areas. The Compliance Department serves as the Chief Privacy Officer and lead the task force.
Pharm-Olam intends that this policy apply to all transfers of personal information, whether in electronic, paper or verbal format, received or made by Pharm-Olam. The provisions of this policy apply to all officers, directors, employees, stockholders, contractors, subcontractors, agents and consultants of Pharm-Olam.
For purposes of this policy, the following definitions shall apply:
- "Agent" means any third party that uses personal information provided to it by or on behalf of Pharm-Olam to perform tasks on behalf of and under the instructions of Pharm-Olam.
- "Pharm-Olam" means Pharm-Olam International, LLC., together with its successors, affiliates, subsidiaries, divisions and groups in the United States and other countries worldwide.
- "Personal Information" means any individual’s information or set of information that Pharm-Olam has or may have in the future that identifies or could be used by or on behalf of Pharm-Olam to identify an individual. Personal information does not include information that is encoded or anonymized or publicly available information that has not been combined with non-public personal information.
- "Sensitive Personal Information" means personal information that reveals race, ethnic origin, political opinions, religious or philosophical beliefs, criminal records or trade union membership, or that concerns health or sex life. In addition, Pharm-Olam treats as sensitive personal information any information received from a third party where that third party treats and identifies the information as sensitive.
Pharm-Olam intends that transfers of personal information are received or made by Pharm-Olam in accordance with the data protection privacy principles of any and all applicable international laws and regulations, including but not limited to the Privacy Principles and the EU Countries’ Data Protection Principles.
The Privacy Principles and the EU Countries’ and Switzerland’s Data Protection Principles are set forth below:
Where Pharm-Olam collects personal information directly from individuals in the European Union, Switzerland and any other country, it will inform them about the types of information gathered, the purposes for which it collects and uses personal information about them, the types of non-agent third parties to which Pharm-Olam discloses that information, and the choices and means Pharm-Olam offers individuals for limiting the use and disclosure of their personal information. Notice will be provided in clear and conspicuous language when individuals are first asked to provide personal information to Pharm-Olam, or as soon as practicable thereafter, and in any event before Pharm-Olam uses or discloses the information for a purpose other than for which it was originally collected.
Where Pharm-Olam receives personal information from its subsidiaries, affiliates or other entities in the EU, Switzerland and any other country, it will use such information in accordance with the notices provided by such entities and the choices made by the individuals to whom such personal information relates.
Pharm-Olam will offer individuals the opportunity to choose (opt-out) whether their personal information is: (1) to be disclosed to a third party; or (2) to be used for a purpose other than the purpose for which it was originally collected or subsequently authorised by the individual. For sensitive personal information, Pharm-Olam will give individuals the opportunity to affirmatively or explicitly (opt in) consent to the disclosure of the information to a third party or use for a purpose other than the purpose for which it was originally collected or subsequently authorised by the individual. Pharm-Olam shall treat sensitive personal information received from an individual the same as the individual would treat and identify it as sensitive personal information.
Pharm-Olam will obtain consent from all customers, employees, healthcare professionals, medical research subjects, clinical investigators, customers, business partners, contractors, subcontractors, consultants and investors, where required, for processing, use and/or distribution of any personal and/or sensitive personal information prior to the processing, use or distribution of such information.
Pharm–Olam will use personal information only in ways that are compatible with the purposes for which it was collected or authorised by the individual. To the extent necessary for those purposes, Pharm-Olam will take reasonable steps to ensure that personal information is relevant to its intended use, accurate, complete, and current.
With the increasing number of countries restricting or disallowing the use of subjects’ initials as an identifier, Pharm-Olam will no longer collect subjects’ initials except where the sponsor requires such, and the Sponsor is compliant with the applicable national laws.
Pharm-Olam may share an individual's information with agents, contractors or partners of Pharm-Olam in connection with services that these individuals or entities perform for, or with, Pharm-Olam. Pharm-Olam will obtain assurances that these agents, contractors or partners subscribe to the Principles, will safeguard all data in line with this policy, and will agree in writing to provide an adequate level of privacy protection in compliance with this policy. Pharm-Olam shall remain liable under the Principles if its agent processes such personal information in a manner inconsistent with the Principles, unless the organization proves that it is not responsible for the event giving rise to the damage.
Pharm-Olam will ensure reasonable safeguards are in place to protect personal information in its possession from loss, misuse and unauthorised access, disclosure, alteration and destruction. Pharm-Olam has put in place appropriate physical, electronic and managerial procedures to safeguard and secure the personal information from loss, misuse and unauthorised access, disclosure, alteration and destruction. Specifically, for personal information subject to electronic storage or transmission, Pharm-Olam maintains a private, secure global network that is protected from malicious computer virus infections and is monitored for unauthorised access. Both electronic and paper based records holding personal information are maintained in access controlled facilities for which business continuity plans are required.
Pharm-Olam shall allow an individual access to their personal information and allow the individual to correct, amend, or delete inaccurate information, except where the burden or expense of providing access would be disproportionate to the risks to the privacy of the individual in the case in question or where the rights of persons other than the individual would be violated. Due to regulatory, statistical, and contractual requirements, Pharm-Olam is not able to grant direct access to research data to research participants or others not directly involved and for valid reasons.
If a complaint or dispute cannot be resolved through our internal process, Pharm-Olam agrees to cooperate and comply with the EU data protection authorities and the Federal Data Protection and Information Commissioner of Switzerland and all other countries.
If a complaint or dispute cannot be resolved through our internal process, Pharm-Olam have appointed an Alternative Dispute Resolution (ADR) and agrees to cooperate and comply with the EU data protection authorities and all other countries.
Any employee that Pharm-Olam determines to be in violation of this policy will be subject to disciplinary action and this may result in termination of their employment with Pharm-Olam.
Any complaints or disputes with regards to this policy should be directed via email to the Pharm-Olam Chief Privacy Officer at ChiefPrivacyOfficer@pharm-olam.com(link sends e-mail).
Pharm-Olam reserves the right to amend this policy from time to time to ensure it remains consistent with the Principles.
Reservation of Rights
Pharm-Olam reserves the right to share individuals’ personal information as required by law or duly authorised information request of governmental authorities.
Information Subject to Other Policies